![LIDR building](/sites/default/files/featured-img/2021-12/lidr.jpg)
The University of Missouri Laboratory for Infectious Disease Research (LIDR) is a Regional Biocontainment Laboratory located on the MU-Columbia campus. LIDR is a critical resource for University of Missouri faculty and collaborating scientists who perform research on infectious diseases and is part of our nation's effort to protect public health.
LIDR journal publications
![Aerosol](/sites/default/files/styles/large/public/2021-12/aresol.jpg?itok=wzOHVzGn)
Aerobiology Core
LIDR offers custom designed aerosol exposure services for BSL-2 and BSL-3 agents. All challenges are performed within a custom-designed and -built GermFreeTM Class III biological safety cabinet for optimal containment and user protection.
![Immunology](/sites/default/files/styles/large/public/2021-12/immun.jpg?itok=0tNeTH9_)
Immunology Core
The LIDR Immunology Core offers flow cytometry, cell sorting and fluorescence microscopy services for fixed or live BSL-1, BSL-2, and BSL-3 samples.
![Microbiology](/sites/default/files/styles/large/public/2021-12/micro.jpg?itok=ShhF0JD9)
Microbiology Core
LIDR has over 10,000 net sq. feet of state-of-the-art laboratory space available for scientists and collaborators for the performance of molecular biology, cell biology and microbiology research under BSL-2 and BSL-3 conditions.
![Immunospot S6 Ultimate M2 screen](/sites/default/files/styles/large/public/2023-11/aims-thmb.jpg?itok=mliy9R77)
Animal Infection and Monitoring Services (AIMS) Core
AIMS can support work on agents up to BSL-3 in a variety of animal models and routes of infection and access to up-to-date instrumentation.
![Research with test tube](/sites/default/files/styles/large/public/2021-12/research.jpg?itok=smpYzaKL)
Research
World-renowned and internationally acclaimed faculty from MU study infectious diseases including arbovirus, brucellosis, plague, Q-fever and tularemia in the LIDR's research programs. Their research is mainly focused on host-pathogen interactions, immune responses in the host and the development of novel vaccines and therapeutics against disease.